These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 17141811)

  • 1. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S; Graf M; Anheuer ZE; Bagdy G
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP; Bouvard M; Stinus L
    Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of post-synaptic 5-HT(1A) receptors in the dorsal hippocampus prevents learned helplessness development.
    Joca SR; Padovan CM; Guimarães FS
    Brain Res; 2003 Jul; 978(1-2):177-84. PubMed ID: 12834912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rats selectively bred for responsiveness to 5-hydroxytryptamine(1A) receptor stimulation: differences in differential reinforcement of low rate 72-second performance and response to serotonergic drugs.
    Cousins MS; Vosmer G; Overstreet DH; Seiden LS
    J Pharmacol Exp Ther; 2000 Jan; 292(1):104-13. PubMed ID: 10604936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.
    Dawson LA; Nguyen HQ; Smith DI; Schechter LE
    Br J Pharmacol; 2000 Jun; 130(4):797-804. PubMed ID: 10864885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
    Dias Elpo Zomkowski A; Oscar Rosa A; Lin J; Santos AR; Calixto JB; Lúcia Severo Rodrigues A
    Brain Res; 2004 Oct; 1023(2):253-63. PubMed ID: 15374751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H; Wang W; Jiang Z; Shang J; Zhang L
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.
    de Jong TR; Pattij T; Veening JG; Dederen PJ; Waldinger MD; Cools AR; Olivier B
    Neuroscience; 2005; 134(4):1351-61. PubMed ID: 16019152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J; Sarkar J; Hiegel C; Uphouse L
    Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
    Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
    Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
    de Jong TR; Snaphaan LJ; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Eur Neuropsychopharmacol; 2006 Jan; 16(1):39-48. PubMed ID: 16107310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.